Genscript Biotech is trading at 1.84 as of the 27th of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.84. Genscript Biotech has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 29th of October 2025 and ending today, the 27th of January 2026. Click here to learn more.
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. The company has 2.12 B outstanding shares. More on Genscript Biotech
Genscript Biotech [GNNSF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genscript Biotech's market, we take the total number of its shares issued and multiply it by Genscript Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genscript Biotech classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 2.12 B outstanding shares.
Genscript Biotech has accumulated about 1.26 B in cash with (136.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check Genscript Biotech Probability Of BankruptcyOwnership AllocationGenscript Biotech has a total of 2.12 Billion outstanding shares. Genscript Biotech secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Genscript Ownership Details
About 38.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 200.0. Genscript Biotech recorded a loss per share of 0.17. The entity last dividend was issued on the 5th of June 2017. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.The quote for Genscript Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Genscript Biotech call Brian Min at 86 25 5889 7288 or check out https://www.genscript.com.
Genscript Biotech Investment Alerts
Genscript Biotech generated a negative expected return over the last 90 days
Genscript Biotech may become a speculative penny stock
The company reported the revenue of 510.6 M. Net Loss for the year was (347.87 M) with profit before overhead, payroll, taxes, and interest of 303.48 M.
Genscript Biotech has accumulated about 1.26 B in cash with (136.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Roughly 38.0% of the company shares are held by company insiders
Genscript Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genscript Biotech's market, we take the total number of its shares issued and multiply it by Genscript Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Genscript Profitablity
The company has Profit Margin (PM) of (0.66) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64.
Technical Drivers
As of the 27th of January, Genscript Biotech retains the Standard Deviation of 4.3, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.40). Genscript Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genscript Biotechvariance and value at risk to decide if Genscript Biotech is priced fairly, providing market reflects its last-minute price of 1.84 per share. Please also validate Genscript Biotech jensen alpha, which is currently at (0.18) to confirm the company can sustain itself at a future point.
The output start index for this execution was zero with a total number of output elements of sixty-one. Genscript Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Genscript Biotech price patterns.
Genscript Biotech Predictive Daily Indicators
Genscript Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genscript Biotech pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Genscript Biotech's time-series forecasting models are one of many Genscript Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genscript Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Genscript Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Stock Screener Now
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Other Information on Investing in Genscript Pink Sheet
Genscript Biotech financial ratios help investors to determine whether Genscript Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genscript with respect to the benefits of owning Genscript Biotech security.